# Zyla Life Sciences US Inc. – FDA Inspection, Feb 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/zyla-life-sciences-us-inc/18b89ed6-2edb-4142-9e87-916937909658
Source feed: FDA_Inspections

> FDA inspection 1082491 of Zyla Life Sciences US Inc., February 28, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082491
- Company Name: Zyla Life Sciences US Inc.
- Inspection Date: 2019-02-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Joseph L. Despins](https://www.keypedia.com/people/joseph-l-despins/c84402a8-7ebb-45ab-b1b9-c43a143c5fb8)

Company: https://www.keypedia.com/companies/zyla-life-sciences-us-inc/9afafefd-863b-415c-9b10-3c39950b573b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c